Wednesday, October 28, 2026

Internal EPA documents show scramble for data on Monsanto’s Roundup

Monsanto itself has admitted a lack of extensive safety tests on its formulated products.

Progressive Briefing for Monday, September 10

"How much perjury is too much perjury from a Supreme Court nominee?"

Bike-Powered Farming Program Turns Lawns Into Urban Farms

A landowner or renter with owner consent, can donate their chemical-free lawn to Fleet Farming, which will then build a food-producing plot at least 500 square feet in size.

Monsanto calls for investigation into WHO agency for ignoring Monsanto-funded studies

Glyphosate-based “Roundup” herbicide is probably the most controversial product of Monsanto, one of the world’s most controversial companies. With EU renewal of glyphosate’s license pending, Monsanto is going after the WHO agency that linked the herbicide to cancer in humans.

Monsanto wins $7.7b lawsuit in Brazil – but farmers’ fight to stop its ‘amoral’...

Monsanto has long had the upper hand over the farmers who use its products. But the momentum may be shifting.

Big Pharma Preps to Spend Hundreds of Millions to Keep Drug Prices High

"PhRMA's decision to hike membership dues 50 percent will increase the trade group's considerable coffers to more than $300 million per year," Politico reports
video

Noam Chomsky: Bernie Sanders campaign didn’t fail. It energized millions & shifted U.S. politics

“It’s common to say now that the Sanders campaign failed. I think that’s a mistake. I think it was an extraordinary success, completely shifted the arena of debate and discussion.”

6 ways to put public interest ahead of Big Pharma profits

Increase access to generics, end “evergreening” drug patents, and other ways to put people before profits.
video

Doctors Without Borders: U.S. Should force Pfizer to share covid vaccine technology with Africa

“I think really what should be prioritized is getting vaccinations to low- and middle-income countries and sharing the vaccine technologies.”

Drug prices likely to rise in Trump Administration

If drug costs continue to rise, it’s a good bet that Pharma will benefit far more than people with Medicare.